ArticleThe American journal of tropical medicine and hygiene2025
Comparison between Saliva and Nasopharyngeal Swabs for the Rapid Detection of Respiratory Viruses Using the Roche Cobas® Liat® Polymerase Chain Reaction System in Rural Guatemala.
Article in The American journal of tropical medicine and hygiene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Vaccination and hybrid immunity is associated with SARS-CoV-2 protection but not shedding duration in rural Guatemalan households.Research square · 2026Article
- SARS-CoV-2 secondary attack rates and risks for transmission among agricultural workers and their households in Guatemala, 2022-2023.IJID regions · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We evaluated the performance of saliva compared with nasopharyngeal (NP) swabs for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A/B, and respiratory syncytial virus (RSV) using the Roche cobas® Liat® point-of-care platform (Roche, Basel, Switzerland). Within an existing adult cohort in Guatemala, consenting participants with influenza-like illness (ILI) provided paired saliva and NP swabs, which were tested for SARS-CoV-2, influenza A/B, and RSV on the Liat platform. Among 138 ILI episodes from 123 enrolled subjects, 35/124 (28.2%), 5/135 (3.7%), 6/135 (4.4%), and 7/135 (5.2%) samples were reverse transcription polymerase chain reaction-positive for SARS-CoV-2, influenza A, influenza B, and RSV, respectively. For SARS-CoV-2, saliva/NP agreement was 90.3% (Cohen's kappa = 0.731); 12 (9.7%) of the samples were discordant (three saliva-positive only, nine NP-positive only); and the median cycle threshold (Ct) for saliva was higher than that for NP (26.53 versus 23.54; P = 0.005). In our setting, saliva had a lower viral load correlate (Ct) but maintained a good correlation with NP swabs for the detection of SARS-CoV-2 on the Liat platform.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.